Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: heart disease

Rheumatologist Nathan Wei, MD, Focuses on Alternatives to Surgery for Athletes

Eric Butterman  |  October 14, 2015

Nathan Wei, MD, FACP, FACR, admits that he didn’t exactly agree with the amount certain things were encouraged in his family. “Aspects such as academics and music were focused on so much,” he says. “I wanted to break out from that upbringing. I wanted to add in more of what I wanted to do.” And…

Filed under:ConditionsProfessional TopicsProfilesRheumatoid Arthritis Tagged with:CareerClinicalpatient careProfileRARheumatoid arthritisrheumatologyrhuematologistsurgeryTreatment

Attracting More Medical Students to Rheumatology

Attracting More Medical Students to Rheumatology

Simon M. Helfgott, MD  |  October 13, 2015

Updated Oct. 22, 2015 (revised to delete inaccurate statistics) The cold, hard facts: This year’s rheumatology fellowship applicant pool resembles those of prior years. It is extremely diverse; every continent is represented, save Antarctica. It is somewhat larger, due in part to the growing influx of graduates from the cluster of Caribbean-based medical schools, where…

Filed under:Career DevelopmentOpinionPractice SupportProfessional TopicsRheuminationsSpeak Out RheumWorkforce Tagged with:AC&RAmerican College of Rheumatology (ACR)Career developmentEducationmedical schoolrecruitsrheumatologyTraining

Rheumatoid Arthritis Patients Have More Severe ACS, Poorer Outcomes

Shannon Aymes  |  October 9, 2015

NEW YORK (Reuters Health)—Rheumatoid arthritis (RA) is associated with more-severe acute coronary syndrome and poorer outcomes, according to a new study. “We found that despite the well-researched increased risk of acute coronary events (ACS) in RA, that there was almost no existing data describing clinical characteristics and outcomes of RA- and non-RA patients with ACS,”…

Filed under:ConditionsRheumatoid Arthritis Tagged with:acute coronary syndromeCardiovascular diseaseMyocardial infarctionOutcomesRheumatoid Arthritis (RA)

How Medicare’s Chronic Care Management Payments Could Affect Primary Care

Will Boggs, MD  |  September 23, 2015

(Reuters Health)—Medicare’s new “chronic care management” (CCM) payment program could make it more financially feasible for physicians to deliver services between visits. Under the new program, Medicare could reimburse primary care practices about $40 month for such things as medication management and communication with other doctors for patients who have two or more chronic medical…

Filed under:Practice Support Tagged with:Chronic Care ManagementMedicareprimary care

Connective Tissue Disorders Lack Societal Concern, Financial Support

Simon M. Helfgott, MD  |  September 15, 2015

“Love is the bone and sinew of my curse.” —Sylvia Plath Cutting the Cord Here’s the problem: No one grows up wanting to seek the cure for bursitis—or tendonitis or just about any of the other seemingly mundane maladies afflicting our body’s scaffolding. Meniscal tears, fasciitis, tendinopathies—the list is endless. Chances are, your college essay…

Filed under:ConditionsOpinionResearch RheumRheuminationsSoft Tissue PainSpeak Out Rheum Tagged with:bursitisconnective tissue disorderpatient careResearchrheumatologisttendonitis

Fellow’s Forum Case Report: Limited Cutaneous Systemic Sclerosis

Eunjung Kim, MD, Hyun Bae, MD, Ritu Kathuria, MD, Alexandra Gottdiener, MD, & Girish Sonpal, MD, FACR  |  September 15, 2015

Systemic sclerosis (SSc) is an acquired, sporadic, autoimmune, connective tissue disease with two subsets: limited cutaneous scleroderma (lcSSc) and diffuse cutaneous scleroderma (dcSSc). In the U.S., the annual incidence is about 20 cases per 1 million adults, with a prevalence of about 240 cases per 1 million adults.1 As with other connective tissue disorders, SSc…

Filed under:ConditionsSystemic Sclerosis Tagged with:Clinicalpatient carerheumatologistSystemic sclerosis

Cardiovascular Risk in Tocilizumab Therapy for RA

Kathy Holliman  |  September 15, 2015

Observation and research have confirmed that patients with rheumatoid arthritis (RA) are at greater risk of cardiovascular disease than their peers of similar age and gender, and that traditional risk factors and chronic inflammation associated with RA apparently play a significant role in that risk. However, predicting which patients with rheumatoid arthritis are at greater…

Filed under:ConditionsRheumatoid Arthritis Tagged with:Cardiovascular diseasepatient careRheumatoid arthritisrisktocilizumabTreatment

EULAR 2015: Benefits of Individualizing Exercise Therapy

Rikke Helene Moe, PT, MSc, PhD  |  September 15, 2015

ROME, Italy—The medical environment is increasingly adapting to the possibilities of optimizing care by individualizing medical treatment and tailoring treatment to disease phenotypes. Data suggest that individualizing exercise therapy, an important treatment modality for rheumatic and musculoskeletal diseases, can help control disease, maximize function, minimize functional barriers and decrease the risk of co-morbidity.1,2,3 Personalizing exercise…

Filed under:ConditionsMeeting ReportsRheumatoid Arthritis Tagged with:exercise therapypatient careRArheumatic and musculoskeletal disease phenotypesRheumatoid arthritisRMDTreatment

Global Life Expectancy Rises, but People Live Sicker for Longer

Kate Kelland  |  August 28, 2015

LONDON (Reuters)—People around the world are living longer, but many are also living sicker lives for longer, according to a study of all major diseases and injuries in 188 countries. General health has improved worldwide, thanks to significant progress against infectious diseases, such as HIV/AIDS and malaria, in the past decade and gains in fighting…

Filed under:Professional Topics Tagged with:disabilityglobal healthinfectious diseasemortality

Psoriasis, Psoriatic Arthritis Linked with Arrhythmia

Laura Newman  |  July 29, 2015

NEW YORK (Reuters Health)—Psoriasis is linked to a higher risk for arrhythmia, independent of classic cardiovascular (CV) risk factors, according to a study from Taiwan. “In my practice, arrhythmia as comorbidity is discussed during patient consultation along with other comorbidities,” said senior author Dr. Tsen-Fang Tsai of the Department of Dermatology at National Taiwan University…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:arrhythmiaheartNational Psoriasis FoundationPsoriasis

  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 81
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences